NCT02802137View on ClinicalTrials.gov

24-hour Efficacy and Ocular Surface With Talfuprost and Triple Combined Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

January 31, 2016

Conditions
GlaucomaOcular Surface Disease
Interventions
DRUG

tafluprost

DRUG

tafluprost and dorzolamide/timolol

All Listed Sponsors
lead

Aristotle University Of Thessaloniki

OTHER

NCT02802137 - 24-hour Efficacy and Ocular Surface With Talfuprost and Triple Combined Therapy | Biotech Hunter | Biotech Hunter